Literature DB >> 34178426

Role of Norepinephrine in Schizophrenia: An Old Theory Applied to a New Case in Emergency Medicine.

Takahiko Nagamine1.   

Abstract

Entities:  

Year:  2020        PMID： 34178426      PMCID： PMC8178969     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN： 2158-8333


× No keyword cloud information.
  9 in total

Review 1.  Layer- and area-specific actions of norepinephrine on cortical synaptic transmission.

Authors:  Humberto Salgado; Mario Treviño; Marco Atzori
Journal:  Brain Res       Date:  2016-01-25       Impact factor: 3.252

Review 2.  Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate.

Authors:  Stephen M Stahl
Journal:  CNS Spectr       Date:  2018-06       Impact factor: 3.790

Review 3.  Is elevated norepinephrine an etiological factor in some cases of schizophrenia?

Authors:  Paul J Fitzgerald
Journal:  Psychiatry Res       Date:  2014-01-18       Impact factor: 3.222

4.  Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.

Authors:  D P van Kammen; J Peters; J Yao; W B van Kammen; T Neylan; D Shaw; M Linnoila
Journal:  Arch Gen Psychiatry       Date:  1990-02

5.  Difficulties in assessing adverse drug reactions in clinical trials.

Authors:  C A Naranjo; U Busto; E M Sellers
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1982       Impact factor: 5.067

6.  CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.

Authors:  D P van Kammen; J Peters; W B van Kammen; A Nugent; K L Goetz; J Yao; M Linnoila
Journal:  Biol Psychiatry       Date:  1989-06       Impact factor: 13.382

7.  Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

Authors:  R Phillip Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven A Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

8.  Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface.

Authors:  J E Hardebo; C Owman
Journal:  Ann Neurol       Date:  1980-07       Impact factor: 10.422

Review 9.  Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality.

Authors:  Torgny H Svensson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-10       Impact factor: 5.067
  9 in total
  1 in total

1.  Impact of Lurasidone on Metabolic Parameters and Prolactin Levels Based on Differences of Psychiatric Diagnosis, Dosage, and Introducing Methods: An Observational Study.

Authors:  Masaru Nakamura; Takahiko Nagamine
Journal:  Innov Clin Neurosci       Date:  2022 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.